SL-251131

• Description:

  SL-251131 is a reversible non-specific MAO inhibitor. SL-251131 temporarily blocks both MAO-A and MAO-B enzymes, which are responsible for breaking down neurotransmitters like dopamine. SL-251131 can be used for the study of Parkinson's disease[1].

• UNSPSC:

  12352005

• Target:

  Monoamine Oxidase

• Related Pathways:

  Neuronal Signaling

• Field of Research:

  Neurological Disease

• Smiles:

  O=C1N2C3=CC=C(OCCCC(F)(F)F)C=C3CC[C@@]2([H])[C@H](O1)COC

• Molecular Formula:

  C17H20F3NO4

• Molecular Weight:

  359.34

• References & Citations:

  [1]Korczyn AD, Nussbaum M. Emerging therapies in the pharmacological treatment of Parkinson’s disease. Drugs. 2002 Apr;62 (5) :775-86.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  176773-86-7